We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > voxelotor

News List

Voxelotor Improves Hemoglobin Levels in Sickle Cell Disease drugs
June 26, 2019
Voxelotor Improves Hemoglobin Levels in Sickle Cell Disease.
GBT heads to FDA with sickle cell drug voxelotor pharmaphorum
December 05, 2018
Global Blood Therapeutics (GBT) has persuaded the FDA to accept biomarker data from a phase III trial of sickle cell disease drug voxelotor as part of a filing for accelerated approval.....
FDA agrees accelerated approval pathway for GBT’s voxelotor pharmaceutical-technology
December 05, 2018
The US Food and Drug Administration (FDA) has granted San Francisco-based Global Blood Therapeutics (GBT)’s sickle cell disease (SCD) therapy voxelotor an accelerated approval under the subpart H pathway.